Comparison of proportion of women receiving treatment and delays to treatment in intervention (on-site testing and laboratory testing) and control (laboratory testing only) arms
| Intervention (n=618) | Control (n=175) | Adjusted risk difference (%)* | 95% CI† | |
|---|---|---|---|---|
| No (%) of women receiving | ||||
| No treatment | 125 (20.2) | 34 (19.4) | 2.2 | −9.2 to 13.6 |
| Adequate treatment‡ | 396 (64.1) | 120 (68.6) | 0.3 | −10.4 to 10.9 |
| Intervention | Control | Adjusted mean difference (days)* | 95% CI† | |
|---|---|---|---|---|
| *Risk differences and mean differences are for (intervention-control), and are adjusted for cluster design based on a weighted average of the risk difference within each clinic pair. | ||||
| †CI = confidence interval. | ||||
| ‡Adequate treatment is defined as receiving two or more doses. | ||||
| Mean delays to treatment (in days) | ||||
| First dose | 4 | 21 | −16.3 | −19.8 to −12.7 |
| Second dose | 12 | 30 | −16.9 | −21.7 to −12.1 |
| Third dose | 21 | 37 | −16.0 | −21.0 to −11.1 |